As a narrative review, our primary objective is to offer a broad synthesis of emerging evidence on the insulin–leptin axis in COPD, underscoring the critical interplay between metabolic dysfunction and disease progression. This evidence concerns the gene LEP and chronic obstructive pulmonary disease.